| 摘要 |
<p>This invention is directed to, for example, compounds of formula (I): wherein n, m, R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, R<SUP>6</SUP>, R<SUP>7</SUP> and R<SUP>8</SUP> are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, for the treatment of iron disorders. This invention is also directed to pharmaceutical compositions comprising the compounds and methods of using the compounds to treat iron disorders.</p> |
| 申请人 |
XENON PHARMACEUTICALS INC.;CHAFEEV, MIKHAIL;CHAKKA, NAGASREE;CADIEUX, JEAN-JACQUES;FU, JIANMIN;KAMBOJ, RAJENDER;KODUMURU, VISHNUMURTHY;LANGILLE, JOHNATHAN;LIU, SHIFENG;SUN, JIANYU;SVIRIDOV, SERGUEI;ZHANG, ZAIHUI |
发明人 |
CHAFEEV, MIKHAIL;CHAKKA, NAGASREE;CADIEUX, JEAN-JACQUES;FU, JIANMIN;KAMBOJ, RAJENDER;KODUMURU, VISHNUMURTHY;LANGILLE, JOHNATHAN;LIU, SHIFENG;SUN, JIANYU;SVIRIDOV, SERGUEI;ZHANG, ZAIHUI |
